Nevada NCORP — Las Vegas, Nevada

Nevada NCORP is a clinical research site located in Las Vegas, Nevada, United States 89106.

Crixeo Clinical Trials Trust Score: 13/100 (FAILING). This profile has not yet been claimed by the site owner.

Nevada NCORP has participated in 3 clinical trials.

Therapeutic areas: Adult Solid Neoplasm, Toxicity, Lymphoma.

Sponsors: Supriya Mohile, Gary Morrow.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Las Vegas

Browse all research sites in Nevada · View every site in Las Vegas

• University of Nevada at Las Vegas
• University Nevada - Las Vegas
• VA Southern Nevada Healthcare
• Sunrise Hospital
• University of Nevada Las Vegas
• Cure 4 The Kids Foundation, A Division of Roseman University of Health Sciences
• University of Nevada School of Medicine
• Sunrise Hospital/eStudySite
• Valley Hospital and Medical Center
• Sunrise Hospital & Medical Center
• MountianView Hospital
• University of Nevada, Las Vegas (UNLV) School of Medicine

Sponsor Feasibility Report

Trust Score: 13/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Nevada NCORP?

Nevada NCORP has a Crixeo Trust Score of 13/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Nevada NCORP conducted?

Nevada NCORP has 3 clinical trials on record. Their work covers Adult Solid Neoplasm, Toxicity, Lymphoma.

Is Nevada NCORP accredited by Crixeo Clinical Trials?

Nevada NCORP has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Nevada NCORP?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.